Literature DB >> 11944923

Species-specific and isoform-specific RNA binding of human and mouse fragile X mental retardation proteins.

Robert B Denman1, Ying Ju Sung.   

Abstract

The loss of the fragile X RNA binding protein, FMRP, causes macroorchidism and mental retardation in man. The discovery of a mouse ortholog led to the development of several FMRP knockout mouse strains that recapitulate some features of the disease. As mouse and human FMRPs differ in several amino acids in their RNA binding domains, we compared the RNA binding profiles of these two orthologs. Five variant FMRPs, whose differences arose from alternative splicing and mutation within the conserved RNA binding domains, were examined. Homoribopolymer binding studies showed that human FMRPs (hFMRP) bound a broader range of single-stranded mimetics than mouse FMRPs (mFMRP) and these interactions were both complex and cooperative. hFMRP and mFMRP also displayed significant preferences toward binding their own mRNA; specifically we found that the mFMRP isoforms bind mFMR1 mRNA much more tightly than their human counterparts. Finally, these data demonstrate that each FMRP variant binds RNAs uniquely, resulting in a set of proteins with differing affinities. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944923     DOI: 10.1006/bbrc.2002.6768

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

2.  A new regulatory function of the region proximal to the RGG box in the fragile X mental retardation protein.

Authors:  Ernest Blackwell; Stephanie Ceman
Journal:  J Cell Sci       Date:  2011-08-24       Impact factor: 5.285

3.  Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1.

Authors:  Timothy L Evans; Mihaela-Rita Mihailescu
Journal:  Protein Expr Purif       Date:  2010-06-10       Impact factor: 1.650

4.  A presynaptic role for FMRP during protein synthesis-dependent long-term plasticity in Aplysia.

Authors:  Sally M Till; Hsiu-Ling Li; Maria Concetta Miniaci; Eric R Kandel; Yun-Beom Choi
Journal:  Learn Mem       Date:  2010-12-21       Impact factor: 2.460

5.  Splice form-dependent regulation of axonal arbor complexity by FMRP.

Authors:  Stephanie E Zimmer; Steven G Doll; A Denise R Garcia; Michael R Akins
Journal:  Dev Neurobiol       Date:  2016-10-03       Impact factor: 3.964

6.  The conserved alternative splicing factor caper regulates neuromuscular phenotypes during development and aging.

Authors:  M Brandon Titus; Ethan G Wright; Jeremy M Bono; Andrea K Poliakon; Brandon R Goldstein; Meg K Super; Lauren A Young; Melpomeni Manaj; Morgan Litchford; Noreen E Reist; Darrell J Killian; Eugenia C Olesnicky
Journal:  Dev Biol       Date:  2021-01-27       Impact factor: 3.582

7.  Conformational-dependent and independent RNA binding to the fragile x mental retardation protein.

Authors:  Xin Yan; Robert B Denman
Journal:  J Nucleic Acids       Date:  2011-05-29

8.  341 Repeats Is Not Enough for Methylation in a New Fragile X Mouse Model.

Authors:  Steven Colvin; Nick Lea; Qiangge Zhang; Martin Wienisch; Tobias Kaiser; Tomomi Aida; Guoping Feng
Journal:  eNeuro       Date:  2022-09-12

9.  Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.

Authors:  Z Zeier; A Kumar; K Bodhinathan; J A Feller; T C Foster; D C Bloom
Journal:  Gene Ther       Date:  2009-07-02       Impact factor: 5.250

Review 10.  The new (dis)order in RNA regulation.

Authors:  Aino I Järvelin; Marko Noerenberg; Ilan Davis; Alfredo Castello
Journal:  Cell Commun Signal       Date:  2016-04-06       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.